Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer
Translational Oncology · 2024-08 · 46 · 102003
DOI: 10.1016/j.tranon.2024.102003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2024-08. Verfasst von Luis Eduardo Rosa Zucca und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil; Instituto do Câncer Brasil, Taubaté, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
METHODS: One-hundred-six patients diagnosed with non-muscle invasive bladder cancer and treated with intravesical BCG were included and divided into two groups, BCG-responsive (n = 47) and -unresponsive (n = 59). Immunohistochemistry was used to evaluate PD-L1 expression and MSI was assessed by a commercial multiplex PCR kit. The mRNA expression profile of 15 immune checkpoints was performed using the nCounter technology. For in silico validation, two distinct cohorts sourced from the Gene Expression Omnibus (GEO) database were used. RESULTS: Among the 106 patients, only one (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil; Instituto do Câncer Brasil, Taubaté, Brazil.
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
- Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Barretos, Brazil.
- Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal.
- Pathology Department, Barretos Cancer Hospital, Barretos, Brazil.
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil; Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal; 3ICVS/3B's-PT Government Associat…
Zitieren
APA
Zucca, L. E. R., Laus, A. C., Sorroche, B. P., Paro, E., Sussuchi, L., Marques, R. F., Teixeira, G. R., Berardinelli, G. N., Arantes, L. M. R. B., Reis, R. M., & Cárcano, F. M. (2024). Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer. Translational Oncology, 46, 102003. https://doi.org/10.1016/j.tranon.2024.102003
Vancouver
Zucca LER, Laus AC, Sorroche BP, Paro E, Sussuchi L, Marques RF, et al. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer. Translational Oncology. 2024;46:102003. doi:10.1016/j.tranon.2024.102003
BibTeX
@article{Zucca2024,
author = {Zucca, Luis Eduardo Rosa and Laus, Ana Carolina and Sorroche, Bruna Pereira and Paro, Eduarda and Sussuchi, Luciane and Marques, Rui Ferreira and Teixeira, Gustavo Ramos and Berardinelli, Gustavo Noriz and Arantes, Lidia Maria Rebolho Batista and Reis, Rui Manuel and Cárcano, Flavio Mavignier},
title = {Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer},
journal = {Translational Oncology},
year = {2024},
volume = {46},
pages = {102003},
doi = {10.1016/j.tranon.2024.102003}
}
EUVIMED